Cenicriviroc, also known as TAK-652 and TBR-652, is an experimental drug candidate for the treatment of HIV infection. It is being developed by Takeda Pharmaceutical and Tobira Therapeutics. Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors, allowi
Molecular Weight:
793.051
CAS Number:
[497223-28-6]
Formula:
C42H56N4O7S2
* VAT and and shipping costs not included. Errors and price changes excepted